118 related articles for article (PubMed ID: 35062071)
1. RETRACTED: mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3.
Cao L; Wang S; Zhang L; Li J
Biomed Pharmacother; 2022 Feb; 146():112608. PubMed ID: 35062071
[TBL] [Abstract][Full Text] [Related]
2. RETRACTED: Corrigendum to "mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3" [Biomed. Pharmacother. 146 (2022) 112608].
Cao L; Wang S; Zhang L; Li J
Biomed Pharmacother; 2022 Aug; 152():113213. PubMed ID: 35688754
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer.
Qiu R; Qian F; Wang X; Li H; Wang L
Biomed Microdevices; 2019 Feb; 21(1):18. PubMed ID: 30783757
[TBL] [Abstract][Full Text] [Related]
4. Retraction notice to "mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3" [Biomed. Pharmacother. 146 (2022) 112608].
Cao L; Wang S; Zhang L; Li J
Biomed Pharmacother; 2023 Apr; 160():114279. PubMed ID: 36725471
[No Abstract] [Full Text] [Related]
5. Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213].
Cao L; Wang S; Zhang L; Li J
Biomed Pharmacother; 2023 Apr; 160():114280. PubMed ID: 36725470
[No Abstract] [Full Text] [Related]
6. 20(S)-Ginsenoside Rg3-loaded electrospun membranes to prevent postoperative peritoneal adhesion.
Qiu R; Li J; Sun D; Li H; Qian F; Wang L
Biomed Microdevices; 2019 Aug; 21(4):78. PubMed ID: 31414228
[TBL] [Abstract][Full Text] [Related]
7. RETRACTED: Monolayers of pigment-protein complexes on a bare gold electrode: Orientation controlled deposition and comparison of electron transfer rate for two configurations.
Kamran M; Akkilic N; Luo J; Abbasi AZ
Biosens Bioelectron; 2015 Jul; 69():40-5. PubMed ID: 25703727
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the gastroprotective effects of 20 (S)-ginsenoside Rg3 on gastric ulcer models in mice.
Zhang K; Liu Y; Wang C; Li J; Xiong L; Wang Z; Liu J; Li P
J Ginseng Res; 2019 Oct; 43(4):550-561. PubMed ID: 31695563
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers.
Zhao Q; Li P; Jiang J; Hu P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):845-853. PubMed ID: 26470874
[TBL] [Abstract][Full Text] [Related]
10. RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221.
Cheng Z; Xing D
Eur J Pharmacol; 2019 Jun; 853():353-363. PubMed ID: 30928631
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
[TBL] [Abstract][Full Text] [Related]
12. RETRACTED: PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
Xu Y; Lu J; Tang Y; Xie W; Zhang H; Wang B; Zhang S; Hou W; Zou C; Jiang P; Zhang W
Cancer Lett; 2022 Mar; 529():19-36. PubMed ID: 34979165
[TBL] [Abstract][Full Text] [Related]
13. RETRACTED: Effects of high-energy electro-pulsing treatment on microstructure, mechanical properties and corrosion behavior of Ti-6Al-4V alloy.
Ye X; Wang L; Tse ZTH; Tang G; Song G
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():851-860. PubMed ID: 25687017
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
Jeon JH; Lee J; Choi MK; Song IS
Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
[TBL] [Abstract][Full Text] [Related]
15. RETRACTED: Association between peroxisome proliferator-activated receptor, UCP3 and lipoprotein lipase gene polymorphisms and obesity in Chinese adolescents.
Zou Z; Mao L; Chen J; Wang L; Cai W
Obes Res Clin Pract; 2017; 11(1):27-33. PubMed ID: 26483159
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of Microspheres Loaded with 20 (R)-ginsenoside Rg3 Enhances Anti-Fatigue Effect in Mice.
Zhang W; Wang X; Zhang M; Xu M; Tang W; Zhang Y; Lu L; Gao J; Gao S
Curr Drug Deliv; 2017 Sep; 14(6):867-874. PubMed ID: 27834150
[TBL] [Abstract][Full Text] [Related]
17. Influence of polymeric carrier on the disposition and retention of 20(R)-ginsenoside-rg3-loaded swellable microparticles in the lung.
Wang X; Zhang X; Fan L; He H; Zhang X; Zhang Y; Mao S
Drug Deliv Transl Res; 2018 Feb; 8(1):252-265. PubMed ID: 29181833
[TBL] [Abstract][Full Text] [Related]
18. Retraction notice to "PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages" [Cancer Lett. 529 (2022) 19-36].
Xu Y; Lu J; Tang Y; Xie W; Zhang H; Wang B; Zhang S; Hou W; Zou C; Jiang P; Zhang W
Cancer Lett; 2022 Nov; 549():215931. PubMed ID: 36216652
[TBL] [Abstract][Full Text] [Related]
19. Development of liposomal Ginsenoside Rg3: formulation optimization and evaluation of its anticancer effects.
Yu H; Teng L; Meng Q; Li Y; Sun X; Lu J; J Lee R; Teng L
Int J Pharm; 2013 Jun; 450(1-2):250-8. PubMed ID: 23628402
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
Geng L; Fan J; Gao QL; Yu J; Hua BJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
